Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease

Annals of Neurology

Volumn 43, Issue 1, 1998, Pages 32-40

  Zerr, Inga ^a   Bodemer, Monika ^a   Gefeller, Olaf ^a   Otto, Markus ^a   Poser, Sigrid ^a   Wiltfang, Jens ^a   Windl, Otto ^a   Kretzschmar, Hans A ^a   Weber, Thomas ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Marienkrankenhaus Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

14-3-3 PROTEINS; ADULT; AGED; AGED, 80 AND OVER; AMYLOID; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PRIONS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTEINS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 0031914675     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430109     Document Type: Article

References (41)

1. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930
2. Zerr I, Bodemer M, Weber T. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997; 336:874 (Letter)
3. Aitken A. 14-3-3 proteins on the MAP. Trends Biochem Sci 1995;20:95-97
4. Aitken A, Collinge DB, van Heusden BP, et al. 14-3-3 Proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 1992;17:498-501
5. Moussavian M, Potolicchio S, Jones R. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997;336:873-874
6. Will RG, Zeidler M, Brown P, et al. Cerebrospinal fluid test for new-variant Creutzfeldt-Jakob disease. Lancet 1996;348:955 (Letter)
7. Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol 1994;35:385-395
8. Kretzschmar HA, Ironside J, DeArmond S, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996;53:913-920
9. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-188
10. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925
11. Zerr I, Bodemer M, Otto M, et al. Diagnosis of Creutzfeldt-Jakob disease by two dimensional gel electrophoresis of cerebro-spinal fluid. Lancet 1996;348:846-849
12. Zerr I, Bodemer M, Räcker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-1610
13. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996;53:162-165
14. Chazot G, Broussolle E, Lapras CI, et al. New variant of Creutzfeldt-Jakob disease in a 26-year old French man. Lancet 1996;347:1181 (Letter)
15. Kuroiwa Y, Celesia GG, Chung HD. Periodic EEG discharges and status spongiosus of the cerebral cortex in anoxic encephalopathy: a necropsy case report. J Neurol Neurosurg Psychiatry 1982;45:740-742
16. Kuroda Y, Ikeda A, Kurohara K, et al. Occurrence of paroxysmal synchronous EEG discharges in subcortical arteriosclerotic encephalopathy (Binswanger's disease). Intern Med 1993;32:243-246
17. Smith SJ, Kocen RS. A Creutzfeldt-Jakob-like syndrome due to lithium toxicity. J Neurol Neurosurg Psychiatry 1988;51:120-123
18. Koponen H, Honkonen S, Partanen J, Riekkinen PJ. Epileptic attack, delirium, and a Creutzfeldt-Jakob-like syndrome during mianserin treatment. Neuropsychobiology 1990;23:164-168
19. Takahashi M, Kubota F, Nishi Y, Miyanaga K. Persistent synchronous periodic discharges caused by anoxic encephalopathy due to cardiopulmonary arrest. Clin Electroencephalogr 1993; 24:166-172
20. Brick JF, Brick JE, Morgan JJ, Gutierrez AR. EEG and pathologic findings in patients undergoing brain biopsy for suspected encephalitis. Electroencephalogr Clin Neurophysiol 1990;38:58-59
21. Tagliavini F, Prelli F, Porro M, et al. A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun 1992;184:1398-1404
22. Kawashima T, Furukawa H, Doh-ura K, Iwaki T. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;350:68-69 (Letter)
23. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349:99-100 (Letter)
24. Jimi T, Wakayama Y, Shibuya S, et al. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 1992; 211:37-46
25. Mokuno K, Kato K, Kawai K, et al. Neuron specific enolase and S-100 protein levels in CSF of patients with various neurological diseases. J Neurol Sci 1983;60:443-451
26. O'Brien C. Mad cow disease: scant data cause widespread concern. Science 1996;271:1798
27. Otto M, Wiltfang J, Tumani H, et al. Elevated levels of tau-protein in CSF of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210-212
28. Otto M, Stein H, Szudra A, et al. Elevated level of S100 protein concentration in CSF of patients with Creutzfeldt-Jakob disease. Akt Neurol 1996;23:71 (Abstract)
29. Finkenstaedt M, Szudra A, Zerr I, et al. Magnetic resonance imaging of Creutzfeldt-Jakob disease. Radiology 1996;199:793-798
30. Freed E, McCormick F, Ruggieri R. Proteins of the 14-3-3 family associate with Raf and contribute to its activation. Cold Spring Harb Symp Quant Biol 1994;59:187-193
31. Will RG. Slow virus infection of the central nervous system. In: Hayward RD, Quinn NP, Wade JPH, Shorvon SD, eds. Current medical literature. Neurology 1991;7:67-71
32. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, vol 2. 2nd ed. Cold Spring Harbor NY: Cold Spring Harbor Laboratory Press, 1989
33. Nicholl D, Windl O, de Silva R, et al. Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry 1995;58:65-69
34. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci USA 1989;86:2766-2770
35. Windl O, Dempster M, Estibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996;98:259-264
36. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529
37. Chen Z, Fu H, Liu D, et al. A NaCl-regulated plant gene encoding a brain protein homology that activates ADP ribosyltransferase and inhibits protein kinase C. Plant J 1994;6:729-740
38. Tanji M, Horwitz R, Rosenfeld G, Waymire JG. Activation of protein kinase C by purified bovine brain 14-3-3: comparison with tyrosine hydroxylase activation. J Neurochem 1994;63:1908-1916
39. Mastrianni JA, Iannicola C, Myers RM, et al. Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology 1996;47:1305-1312
40. Kenney K, Harrington MG, Gibbs CJJ. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997;336:874-875
41. Martin H, Rostas J, Patel Y, Aitken A. Subcellular localization of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 1994;63:2259-2265